Karin Helsberg

521 total citations
12 papers, 414 citations indexed

About

Karin Helsberg is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Karin Helsberg has authored 12 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Clinical Psychology. Recurrent topics in Karin Helsberg's work include Attention Deficit Hyperactivity Disorder (3 papers), Child and Adolescent Psychosocial and Emotional Development (3 papers) and Diabetes Management and Research (2 papers). Karin Helsberg is often cited by papers focused on Attention Deficit Hyperactivity Disorder (3 papers), Child and Adolescent Psychosocial and Emotional Development (3 papers) and Diabetes Management and Research (2 papers). Karin Helsberg collaborates with scholars based in Germany, United States and Türkiye. Karin Helsberg's co-authors include Alexander Schacht, Peter M. Wehmeier, Regina Dittmann, M Hanefeld, Christof Kazda, Thomas Först, Gerd Lehmkuhl, Wolfgang Schreiber, Michael Kluge and Helmut Petto and has published in prestigious journals such as Diabetes Care, The Journal of Urology and European Urology.

In The Last Decade

Karin Helsberg

12 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Helsberg Germany 10 155 129 118 62 43 12 414
Emanuela Amici Italy 9 293 1.9× 92 0.7× 319 2.7× 23 0.4× 94 2.2× 17 510
Hiroki Horita Japan 11 173 1.1× 91 0.7× 276 2.3× 27 0.4× 157 3.7× 27 516
Morgan Bron United States 14 146 0.9× 103 0.8× 18 0.2× 77 1.2× 67 1.6× 42 641
Sandrine Compagnie France 10 184 1.2× 20 0.2× 224 1.9× 25 0.4× 108 2.5× 16 344
RJ Krane United States 8 219 1.4× 66 0.5× 357 3.0× 37 0.6× 152 3.5× 12 459
Pierre Lavoisier France 8 107 0.7× 43 0.3× 225 1.9× 11 0.2× 90 2.1× 13 284
K-E. Andersson Sweden 10 146 0.9× 29 0.2× 185 1.6× 37 0.6× 141 3.3× 17 390
M Meduri Italy 11 18 0.1× 30 0.2× 154 1.3× 25 0.4× 12 0.3× 27 343
Robert B. Moreland United States 6 261 1.7× 88 0.7× 437 3.7× 57 0.9× 221 5.1× 9 518
Anthony E. Falone United States 7 31 0.2× 30 0.2× 95 0.8× 31 0.5× 3 0.1× 9 345

Countries citing papers authored by Karin Helsberg

Since Specialization
Citations

This map shows the geographic impact of Karin Helsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Helsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Helsberg more than expected).

Fields of papers citing papers by Karin Helsberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Helsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Helsberg. The network helps show where Karin Helsberg may publish in the future.

Co-authorship network of co-authors of Karin Helsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Helsberg. A scholar is included among the top collaborators of Karin Helsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Helsberg. Karin Helsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dittmann, Regina, Alexander Schacht, Karin Helsberg, et al.. (2011). Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany. Journal of Child and Adolescent Psychopharmacology. 21(2). 97–110. 36 indexed citations
2.
Gallwitz, Baptist, Thomas Segiet, K Milek, et al.. (2011). Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes. Diabetes Care. 34(3). 604–606. 76 indexed citations
3.
4.
Wehmeier, Peter M., Regina Dittmann, Alexander Schacht, Karin Helsberg, & Gerd Lehmkuhl. (2009). Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies. Child and Adolescent Psychiatry and Mental Health. 3(1). 5–5. 24 indexed citations
5.
6.
7.
Wehmeier, Peter M., Michael Kluge, Alexander Schacht, et al.. (2007). Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Journal of Psychiatric Research. 42(8). 676–683. 12 indexed citations
8.
Wehmeier, Peter M., Michael Kluge, Alexander Schacht, Karin Helsberg, & Wolfgang Schreiber. (2007). Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophrenia Research. 91(1-3). 178–186. 35 indexed citations
9.
10.
Scharla, Stephan, et al.. (2006). Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration. Current Medical Research and Opinion. 22(12). 2393–2402. 26 indexed citations
11.
Leschinger, Monika I., Karin Helsberg, Frank Langer, & Wolfgang Schütte. (2005). Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnisübersicht randomisierter Phase-III-Studien. Oncology Research and Treatment. 28(1). 1–28. 6 indexed citations
12.
Jacob, Simon N., et al.. (2004). Effects of Moxonidine vs. Metoprolol on Blood Pressure and Metabolic Control in Hypertensive Subjects with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 112(6). 315–322. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuela Amici Breakdown of academic impact, for papers by Hiroki Horita Breakdown of academic impact, for papers by Morgan Bron Breakdown of academic impact, for papers by Sandrine Compagnie Breakdown of academic impact, for papers by RJ Krane Breakdown of academic impact, for papers by Pierre Lavoisier Breakdown of academic impact, for papers by K-E. Andersson Breakdown of academic impact, for papers by M Meduri Breakdown of academic impact, for papers by Robert B. Moreland Breakdown of academic impact, for papers by Anthony E. Falone
Rankless by CCL
2026